Chart of the Day: Goldman Sachs (GS)

NYSE: GS | Goldman Sachs Group, Inc. (The)  News, Ratings, and Charts

GS – Goldman Sachs (GS) has tested it’s trend line 5 times in the past 3.5 months.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Since hitting 52-week lows in March, Goldman Sachs (GS) has been trending higher.  As it does, a trend line and a support level have formed, which can be helpful to investors looking to trade this stock.

A trend line is a straight line connecting at least two price points and then extends into the future to act as a line of support or resistance.  It’s my opinion that any 2 points can start a trend line but when the stock tests the trend line 3 times or more, it becomes more relevant.

In this case, GS has tested it’s trend line (blue) 5 times in the past 3.5 months.

Also in the chart below, you’ll see that I have identified a support level (green) at $195.

Notice that right now the trend line and the support level are intersecting at $195.

Take a look at the 1-year chart of GS below with added notations:

Chart of GS provided by TradingView

If GS falls under $195, a trader could enter a short position with the expectation that there will be a breakdown lower in the stock price because the trendline and support level would be breached.

Why could this stock move lower?  Because banks have been hit hard COVID-19. GS is currently trading about 20% off it’s 52-week high, as the S&P 500 is only down about 7%.  

Keep an eye on GS and be mindful of their next earnings report which will be released on August 10th.

Have a good trading day!

Christian Tharp, CMT


Stock Trading & Investing for Everyone

Want More Great Investing Ideas?

9 “BUY THE DIP” Growth Stocks for 2020

Is the Bull S#*t Rally FINALLY Over?

7 “Safe-Haven” Dividend Stocks for Turbulent Times

Top 3 Investing Strategies for 2020

GS shares were trading at $200.73 per share on Friday morning, up $3.90 (+1.98%). Year-to-date, GS has declined -11.62%, versus a -1.31% rise in the benchmark S&P 500 index during the same period.

About the Author: Christian Tharp

Christian is an expert stock market coach at the Adam Mesh Trading Group who has mentored more than 4,000 traders and investors. He is a professional technical analyst that is a certified Chartered Market Technician (CMT), which is a designation awarded by the CMT Association. Christian is also the author of the daily online newsletter Todays Big Stock. More...

More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
GSGet RatingGet RatingGet Rating

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Top Stories on

NASDAQ: MDLZ | Mondelez International, Inc. -  News, Ratings, and Charts

5 Food Stocks for PROFIT-HUNGRY Investors

One effect of the coronavirus is that more people are cooking and eating at home. As a result, food stocks have been very strong. MDLZ, HSY, K, HAIN, and THS are five of the highest-quality food stocks for the second half of the year.
NYSE: CAT | Caterpillar, Inc.  News, Ratings, and Charts

5 Recently Upgraded Stocks to BUY Right Now!

Our exclusive POWR Ratings have recently upgraded a number of stocks based on a number of positive factors. Here are five upgraded stocks that you should buy now: Caterpillar (CAT), The Estee Lauder Companies (EL), Applied Materials (AMAT), Stanley Black & Decker (SWK) and U.S. Xpress Enterprises (USX).
: CVNA | Carvana Co.  News, Ratings, and Charts

4 Stocks with IMPRESSIVE Revenue Growth

While the economy has struggled since the pandemic started, there are companies still seeing revenue growth. Here are four stocks with strong revenue growth: Carvana (CVNA), Sarepta Therapeutics (SRPT), BeiGene (BGNE) and CRISPR Therapeutics (CRSP).
NYSE: ABBV | AbbVie Inc.  News, Ratings, and Charts

3 Healthcare Stocks with Over 3% Dividend Yield

The healthcare sector has come to the forefront as the cornonavirus pandemic has influenced our daily activities. Some stocks are worth your time, while others aren't. If you're looking for dividend income, here are 3 healthcare stocks with dividend yields over 3%: AbbVie Inc. (ABBV), Pfizer, Inc. (PFE) and Patterson Companies, Inc. (PDCO).
NYSE: PE | Parsley Energy, Inc.  News, Ratings, and Charts

4 Undervalued Mid-Cap Stocks with EXPLOSIVE Growth Potential

The mid-cap segment of the market has under-performed over the last couple months leading me to believe there are attractive mid-cap stocks with strong growth potential: Parsley Energy (PE), Western Union (WU), Canadian Solar (CSIQ), and Diamondback Energy (FANG).

Read More Stories

More Goldman Sachs Group, Inc. (The) (GS) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All GS News